104 related articles for article (PubMed ID: 7850755)
21. Impact on second malignancy risk of the combined use of radiation and chemotherapy for lymphomas.
Lavey RS; Eby NL; Prosnitz LR
Cancer; 1990 Jul; 66(1):80-8. PubMed ID: 2354413
[TBL] [Abstract][Full Text] [Related]
22. Sequential bcl-2 and c-myc oncogene rearrangements associated with the clinical transformation of non-Hodgkin's lymphoma.
Lee JT; Innes DJ; Williams ME
J Clin Invest; 1989 Nov; 84(5):1454-9. PubMed ID: 2509518
[TBL] [Abstract][Full Text] [Related]
23. Polymorphisms in the interleukin 10 gene promoter are associated with susceptibility to aggressive non-Hodgkin's lymphoma.
Cunningham LM; Chapman C; Dunstan R; Bell MC; Joske DJ
Leuk Lymphoma; 2003 Feb; 44(2):251-5. PubMed ID: 12688341
[TBL] [Abstract][Full Text] [Related]
24. [Association of gene polymorphisms in the DNA repair gene XPD with risk of non-Hodgkin's lymphoma].
Song B; Zhu JY; Liu J; Wang ZH; Shi Y; Lü LY; Zheng Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):97-100. PubMed ID: 18315909
[TBL] [Abstract][Full Text] [Related]
25. CXCL12 rs18011157 polymorphısm in patients wıth non-Hodgkin's lymphoma: Is it associated with poor outcome?
Pamuk GE; Tozkır H; Uyanık MS; Gurkan H; Duymaz J; Pamuk ON
J Cancer Res Ther; 2018; 14(5):1075-1078. PubMed ID: 30197351
[TBL] [Abstract][Full Text] [Related]
26. Polymorphism in the tumor necrosis factor-alpha promotor region and in the heat shock protein 70 genes associated with malignant tumors.
Chouchane L; Ahmed SB; Baccouche S; Remadi S
Cancer; 1997 Oct; 80(8):1489-96. PubMed ID: 9338474
[TBL] [Abstract][Full Text] [Related]
27. XbaI RFLP of ETS-1 oncogene in chronic B-cell leukaemia.
Crossen PE; Morrison MJ
Leukemia; 1992 Aug; 6(8):843-4. PubMed ID: 1353551
[TBL] [Abstract][Full Text] [Related]
28. p380-8A 1.8 SaSs, a single copy clone 5' of c-myc at 8q24 which recognizes an SstI polymorphism.
Haluska FG; Huebner K; Croce CM
Nucleic Acids Res; 1987 Jan; 15(2):865. PubMed ID: 2881266
[No Abstract] [Full Text] [Related]
29. Tumor necrosis factor promoter gene polymorphism associated with increased susceptibility to non-Hodgkin's lymphomas.
Bel Hadj Jrad B; Chatti A; Laatiri A; Ahmed SB; Romdhane A; Ajimi S; Chouchane L
Eur J Haematol; 2007 Feb; 78(2):117-22. PubMed ID: 17087739
[TBL] [Abstract][Full Text] [Related]
30. 3' untranslated region A>C (rs3212227) polymorphism of Interleukin 12B gene as a potential risk factor for Hodgkin's lymphoma in Brazilian children and adolescents.
Silva OB; Correia NAA; de Barros FT; de Lima LPO; Morais A; Hassan R; Dellalibera E; de Mendonça Cavalcanti MDS; Muniz MTC
Tumour Biol; 2019 Jul; 41(7):1010428319860400. PubMed ID: 31277552
[TBL] [Abstract][Full Text] [Related]
31. HLA-A*26 and susceptility of iranian patients with non-Hodgkin lymphoma.
Sayad A; Akbari MT; Mehdizadeh M; Taheri M; Hajifathali A
Iran J Immunol; 2014 Dec; 11(4):269-74. PubMed ID: 25549594
[TBL] [Abstract][Full Text] [Related]
32. Involvement of the bcl-2 gene in Hodgkin's disease.
Stetler-Stevenson M; Crush-Stanton S; Cossman J
J Natl Cancer Inst; 1990 May; 82(10):855-8. PubMed ID: 2185367
[TBL] [Abstract][Full Text] [Related]
33. Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma.
Diepstra A; Niens M; Vellenga E; van Imhoff GW; Nolte IM; Schaapveld M; van der Steege G; van den Berg A; Kibbelaar RE; te Meerman GJ; Poppema S
Lancet; 2005 Jun 25-Jul 1; 365(9478):2216-24. PubMed ID: 15978930
[TBL] [Abstract][Full Text] [Related]
34. Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-Frankfurt-Münster Trial NHL-BFM 95.
Seidemann K; Zimmermann M; Book M; Meyer U; Burkhardt B; Welte K; Reiter A; Stanulla M
J Clin Oncol; 2005 Nov; 23(33):8414-21. PubMed ID: 16293872
[TBL] [Abstract][Full Text] [Related]
35. Association of stromal cell-derived factor-1-3'A polymorphism to higher mobilization of hematopoietic stem cells CD34+ in Tunisian population.
Ben Nasr M; Reguaya Z; Berraies L; Maamar M; Ladeb S; Ben Othmen T; Mellouli F; Béjaoui M; Domenech J; Jenhani F
Transplant Proc; 2011 Mar; 43(2):635-8. PubMed ID: 21440782
[TBL] [Abstract][Full Text] [Related]
36. Non-Hodgkin's lymphoma and family history of hematologic malignancy.
Mensah FK; Willett EV; Ansell P; Adamson PJ; Roman E
Am J Epidemiol; 2007 Jan; 165(2):126-33. PubMed ID: 17071845
[TBL] [Abstract][Full Text] [Related]
37. [Relationships between CASP8, Fas Gene Polymorphisms and the Prognosis of Patients with Non-Hodgkin's Lymphoma in Han Nationality].
Huang Y; Hu S; Cui WT
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Oct; 29(5):1493-1497. PubMed ID: 34627429
[TBL] [Abstract][Full Text] [Related]
38. Cytotoxic T-lymphocyte antigen-4 (CTLA-4) gene polymorphism and susceptibility to non-Hodgkin's lymphoma.
Monne M; Piras G; Palmas A; Arru L; Murineddu M; Latte G; Noli A; Gabbas A
Am J Hematol; 2004 May; 76(1):14-8. PubMed ID: 15114591
[TBL] [Abstract][Full Text] [Related]
39. Analysis of the association of polymorphic loci rs917997 in IL18RAP gene and rs187238 in IL18 gene with the risk for non-Hodgkin's malignant lymphomas in Novosibirsk population.
Surovtseva MN; Vainer AS; Berezina OV; Ovchinnikov VS; Voropaeva EN; Pospelova TI; Filipenko ML
Bull Exp Biol Med; 2014 May; 157(1):66-9. PubMed ID: 24909718
[TBL] [Abstract][Full Text] [Related]
40. Single nucleotide polymorphism in 5'-flanking region of BCL6 is not associated with increased risk of non-Hodgkin's lymphoma.
Susova S; Trneny M; Soucek P
Cancer Lett; 2006 Jul; 238(1):142-5. PubMed ID: 16125304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
